North Wales based PharmaGroup has announced it has successfully completed the acquisition of HayMax, one of the UK's leading brands in hay fever and allergy relief.
This strategic move significantly strengthens PharmaGroup's commitment to developing and growing in the natural health and wellbeing sector.
HayMax, renowned for its organic, drug-free, 100% natural allergen barrier balms, has established itself as a trusted name among airborne allergy sufferers across the UK over the last 20 years. Its innovative approach to trapping pollen, dust, and pet allergens before they enter the body aligns perfectly with PharmaGroup’s existing ethos and new product development pipeline.
“We are absolutely thrilled to welcome HayMax into the PharmaGroup family,” said Mared Bunsee, Business Development Manager at PharmaGroup.
“HayMax is a truly brilliant brand that has earned the loyalty of its users through its commitment to organic, natural and effective allergy relief.”
Max Wiseberg, creator and Founder of HayMax says:
“I am delighted to pass HayMax on to PharmaGroup who have already started adding value to the brand. Their resources and manufacturing facility will provide HayMax with greater flexibility to react to customers’ needs and I think you can all look forward to more new product development before too long.”
He added:
“I am also proud and pleased that PharmaGroup have taken on board the Organic message and will be getting their facilities up to Organic standards as soon as possible.”
PharmaGroup is committed to maintaining the high standards of quality and efficacy that HayMax customers have come to expect, while exploring new avenues for growth and product development within the natural health sector.
PharmaGroup have bought all the shares of HayMax meaning they can continue to run the business with no changes required for customers or suppliers.
